advertisement

---

Current opinion in pharmacology 10

Showing records 1 to 10 | Display all abstracts in Current opinion in pharmacology

118622 Optic nerve regeneration: Potential treatment approaches
Lee J
Current opinion in pharmacology 2024; 74: 102428

---

117766 Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review
Benitez B
Current opinion in pharmacology 2024; 74: 102424

---

117621 Integrating network pharmacology: The next-generation approach in ocular drug discovery
Lazzara F
Current opinion in pharmacology 2024; 74: 102425

---

117961 Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drug
Sharif NA
Current opinion in pharmacology 2024; 74: 102426

---

117766 Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review
Anter AM
Current opinion in pharmacology 2024; 74: 102424

---

118622 Optic nerve regeneration: Potential treatment approaches
Nguyen S
Current opinion in pharmacology 2024; 74: 102428

---

117621 Integrating network pharmacology: The next-generation approach in ocular drug discovery
Conti F; Giuffrida E
Current opinion in pharmacology 2024; 74: 102425

---

118622 Optic nerve regeneration: Potential treatment approaches
Bhattacharya S
Current opinion in pharmacology 2024; 74: 102428

---

117766 Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review
Arcuri J; Bhattacharya SK
Current opinion in pharmacology 2024; 74: 102424

---

117621 Integrating network pharmacology: The next-generation approach in ocular drug discovery
Eandi CM; Drago F; Platania CBM; Bucolo C
Current opinion in pharmacology 2024; 74: 102425

---